Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02960633
Other study ID # 16/073U
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 3, 2016
Last updated November 10, 2016
Start date November 2016

Study information

Verified date November 2016
Source ZOL
Contact n/a
Is FDA regulated No
Health authority Belgium: niet van toepassing
Study type Interventional

Clinical Trial Summary

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Corail prosthesis with or without collar design. Randomized study design focusing on radiolucent lines on standard x-ray.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date
Est. primary completion date November 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- primary THA

Exclusion Criteria:

- fractured hips

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Corail with collar.

Corail without collar.


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
ZOL

Outcome

Type Measure Description Time frame Safety issue
Primary The investigators will measure radiolucent lines on X-ray. Hypothesis: Collar shows more radiolucent lines on xray in Gruen zone 7. 5 year No
See also
  Status Clinical Trial Phase
Completed NCT02970253 - Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention Phase 1